Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$344K Sell
3,478
-74
-2% -$7.73K 0.26% 64
2026
Q2
$322K Sell
3,552
-787
-18% -$71.8K 0.25% 70
2026
Q1
$445K Hold
4,339
– – 0.39% 50
2025
Q4
$544K Buy
+4,339
New +$553K 0.48% 42

Other funds holding ABT

Bayban's ABT Position: Q3 2026 in Review

Bayban reduced its Abbott (ABT) stake by 2.1% in Q3 2026, selling an estimated $7.73K and leaving 3,478 shares worth $344K. The position accounts for 0.26% of the portfolio, ranked #64.

Bayban first reported a position in ABT in Q4 2025 and has held it in 4 quarters since. The position peaked at $544K in Q4 2025. 3,040 funds tracked by Wall St. Rank hold ABT as of Q3 2026.

  • Bayban held 3,478 shares of Abbott worth $344K as of Q3 2026.
  • Bayban sold 74 Abbott shares in Q3 2026, an estimated $7.73K.
  • Abbott made up 0.26% of Bayban's portfolio in Q3 2026, its #64 holding.
  • Bayban first reported a position in Abbott in Q4 2025 and has held it in 4 quarters since.
  • Bayban's Abbott position peaked at $544K in Q4 2025.
  • 3,040 funds tracked by Wall St. Rank held Abbott as of Q3 2026.

Based on Bayban's 13F filing for Q3 2026, filed 5 Nov 2026.